about
Acetylcysteine for preventing contrast-induced nephropathyAcetylcysteine for preventing contrast-induced nephropathyMultiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal diseaseOral and Intravenous Acetylcysteine for Treatment of Acetaminophen Toxicity: A Systematic Review and Meta-analysisOxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-AcetylcysteineGlutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patientsPotential role of N-acetylcysteine in the management of substance use disordersN-acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium sppN-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line DataN-acetylcysteine overdose after acetaminophen poisoning.Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine.Stimuli-responsive star poly(ethylene glycol) drug conjugates for improved intracellular delivery of the drug in neuroinflammationOxidants/antioxidants in idiopathic pulmonary fibrosis.Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children.Respiratory muscle function and free radicals: from cell to COPD.N-acetylcysteine as an antidote in methylmercury poisoning.Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.Mucoactive drugs for asthma and COPD: any place in therapy?N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trialsMuscle-derived ROS and thiol regulation in muscle fatigue.Cardiac function and circulating cytokines after endotoxin exposure in neonatal mice.Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemiaImproved oxidative status in major abdominal surgery patients after N-acetyl cystein supplementationA randomised, double blind trial of N-Acetylcysteine for hearing protection during stapes surgery.Acetaminophen intoxication and length of treatment: how long is long enough?Acetylcysteine and Acetaminophen Overdose: The Many Shades of GrayContrast-induced acute kidney injury and diabetic nephropathy.N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?N-acetylcysteine as a potential antidote and biomonitoring agent of methylmercury exposure.Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue.N-acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients.The role for N-acetylcysteine in the management of COPDN-acetyl cysteine in clomiphene citrate resistant polycystic ovary syndrome: A review of reported outcomesDendrimer-drug conjugates for tailored intracellular drug release based on glutathione levels.Antioxidant therapeutic advances in COPD.Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models.A Systems Approach Implicates a Brain Mitochondrial Oxidative Homeostasis Co-expression Network in Genetic Vulnerability to Alcohol Withdrawal.Intravenous acetylcysteine for the treatment of acetaminophen overdose.Impact of Dietary Antioxidants on Sport Performance: A Review.
P2860
Q24187683-5B199875-43E3-499B-9573-34E8674452B7Q24194049-8F66A582-C415-4FEA-AC3C-FF3DA953535EQ24613855-7C2446B0-4902-43C2-A6D2-A95897F9628AQ24626552-5BDF546A-EF17-422E-8C0C-F237F960A940Q26773384-6563EBA0-6F9C-449A-885E-5853ADA84A8BQ28257370-93FB300F-5568-475B-B5BE-26C76D78C791Q28306130-A282CA57-EAD4-4C49-963F-38434B20A601Q28391846-E527BBF9-2C99-4C83-B6B9-813A86A6E7BFQ30000089-EC51BA2D-2AA6-4E97-B538-A4442F9BE371Q33421183-27D470B2-E500-4519-96AF-8CD82DE55119Q33604291-7142EBE2-48C1-4072-90E7-2FBCA127F542Q33708080-BBA30AAC-FC13-4B58-9C6E-BCEE241E3B3FQ33821300-EE3256EE-0FAC-4D79-8455-B9499EB56E94Q33883674-23B9302A-6F03-449E-9C42-B1183A65013DQ33971084-EFEF67C3-6C92-4EE4-A39A-FCC6A7140625Q34461777-3B498085-7A69-4E20-92D6-584AE201178BQ34463780-6EC3C6FE-112F-42DB-A4CD-F084B4B88A0EQ34481949-45DB5665-1B01-47E0-BD25-241F5383721BQ34543171-AE900935-D7EC-481E-AED3-E05C3C4EA9A7Q34576097-D9DD3E33-9E8B-4F62-9E44-0F37F89B27D7Q34714163-1675A152-CF47-4606-8D70-1C7442D65D2AQ34911516-72E2D549-E920-4376-85BE-E1890D813D29Q35002007-5E6870B9-C276-4258-8EEB-F03C50B04914Q35060309-3D04B582-925E-49F6-82D4-4B6B2735173FQ35170816-74D1D5F4-09E2-48B5-8740-DECE3F93D3CDQ35200882-E4EA97F9-2C46-43BA-B0E4-218080DB412FQ35754032-7B3239D5-4D39-4C9B-A0BB-55A9A6B72064Q35766187-AC3EF57F-46B5-4DB3-B842-669A60F337F9Q36277926-82334A32-898A-407A-BBBB-8765238D3C38Q36381238-FEB86ED6-C996-4E17-8EAB-159DE8CF7D86Q36571501-3AE7ED18-0239-4A81-94A8-9059653106F7Q36947309-A0E2AC50-557F-408F-ACC7-41E1E19AEF38Q37018878-8159BEE1-CF55-4D1C-98ED-4066CFE4DA66Q37102234-4103B3EB-385B-4686-B394-7C6DE511818FQ37307526-04B805C6-6A63-4018-8AF3-E1B323B7EF71Q37348279-B5C49F4B-D2F7-4B6F-B00C-32C881EB15EAQ37418479-83903F00-6F63-472C-A456-7470781AAB42Q37550746-F0688729-58C0-4393-AACD-2C381B672A28Q37815203-989ED521-A544-48E8-83A2-30D04E22A123Q38384148-889C6B8B-AEF1-4A73-A230-45C40D81210C
P2860
description
1986 nî lūn-bûn
@nan
1986 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Pharmacokinetics of N-acetylcysteine in man.
@ast
Pharmacokinetics of N-acetylcysteine in man.
@en
Pharmacokinetics of N-acetylcysteine in man.
@nl
type
label
Pharmacokinetics of N-acetylcysteine in man.
@ast
Pharmacokinetics of N-acetylcysteine in man.
@en
Pharmacokinetics of N-acetylcysteine in man.
@nl
prefLabel
Pharmacokinetics of N-acetylcysteine in man.
@ast
Pharmacokinetics of N-acetylcysteine in man.
@en
Pharmacokinetics of N-acetylcysteine in man.
@nl
P2093
P356
P1476
Pharmacokinetics of N-acetylcysteine in man.
@en
P2093
P2888
P304
P356
10.1007/BF00606662
P577
1986-01-01T00:00:00Z
P6179
1013131035